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Abstract
Matrix metalloproteinases (MMPs) are key biological mediators of processes as diverse as wound 
healing, embryogenesis, and cancer progression. Although MMPs may be induced through 
multiple signaling pathways, the precise mechanisms for their regulation in cancer are 
incompletely understood. Because cytoskeletal changes are known to accompany MMP 
expression, we sought to examine the potential role of the poorly understood cytoskeletal protein, 
nestin, in modulating melanoma MMPs. Nestin knockdown (KD) upregulated expression of 
specific MMPs and MMP-dependent invasion both through extracellular matrix barriers in vitro 
and in peritumoral connective tissue of xenografts in vivo. Development of 3-dimensionsal 
melanospheres that in vitro partially recapitulate non-invasive tumorigenic melanoma growth was 
inhibited by nestin KD, although ECM invasion by aberrant melanospheres that did form was 
enhanced. Mechanistically, nestin KD-dependent melanoma invasion was associated with 
intracellular redistribution of phosphorylated focal adhesion kinase (pFAK) and increased 
melanoma cell responsiveness to transforming growth factor-beta (TGF-β), both implicated in 
pathways of melanoma invasion. The results suggest that the heretofore poorly understood 
intermediate filament, nestin, may serve as a novel mediator of MMPs critical to melanoma 
virulence.
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Introduction
Matrix metalloproteinases (MMPs) are endopeptidases involved in dissolution and 
remodeling of extracellular matrix (ECM) elements. Accordingly they play important roles 
in physiological processes such as embryogenesis and tissue repair, as well as in multistep 
cancer progression where tumorigenic cells in primary lesions acquire the ability to infiltrate 
connective tissue and ultimately to metastasize 1. In melanoma, an established model for 
tumor progression 2, MMPs and their tissue inhibitors (TIMPs) are expressed in both tumor 
cells and tumor stroma, and these two compartments are believed to collaborate in 
facilitating infiltration of malignant cells through ECM and away from the main tumor 
nodule 3. This model is most relevant to the concept of vertical growth of primary melanoma 
where cells both aggregate as expansive nodules driven by self-renewing cells 4 and/or may 
infiltrate into surrounding dermis where they associate with vessels that communicate with 
lymph nodes and/or the peripheral circulation 1, 3, 4. Thus, both tumorigenic and infiltrative 
growth patterns are important and complementary facets of melanoma virulence 1, 3, 4, both 
at primary sites where subsets of tumorigenic cells of the vertical growth phase invade 
stroma and seek access to vessels, and at metastatic loci where migrant cells endeavor to 
reform tumor nodules, thus creating durable metastases.
Multiple signaling pathways are involved in molecular regulation of MMPs 5, with 
cytoskeletal alterations most recently implicated 6. In this regard, melanomas express a 
physiologic stem cell and tumor virulence-associated type VI intermediate filament 
cytoskeletal protein, nestin, the function of which in cancer remains incompletely 
understood 7. Although nestin is a molecule normally associated with neural crest stem 
cells 8 and has been advanced as a melanoma stem cell/initiating cell marker 7, 9, the cellular 
localization of nestin in most melanomas, in our experience, is more ubiquitous than that 
seen in the more discrete and infrequent subsets defined by conventional biomarkers such as 
ABCB5 and CD271 that identify rigorously defined self-renewing cells capable of 
pluripotency 10, 11. Accordingly, we posited that the functional role of nestin in melanoma 
may differ from that of conventional cancer initiating cells 12, 13. Supporting this notion, 
experimental nestin depletion recently has been shown to be associated with invasiveness of 
prostate carcinoma cells 14. We thus initially screened two nestin-expressing and nestin 
knockdown (KD) melanoma cell lines for genes associated with invasion/epithelial 
mesenchymal transition. Among genes analyzed, nestin depletion (as originally observed by 
one of us, QZ), was most significantly associated with upregulation of MMP expression, 
leading to the series of experiments and related observations reported herein. Our data 
suggest that nestin is an important regulator of MMP expression and the invasive phenotype 
in melanoma, and that multiple pathways may converge to influence this nestin/MMP axis.
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Materials and Methods
Study design
Association between nestin sub-cellular distribution and melanoma growth patterns was 
initially explored in 10 primary cutaneous melanomas (5 nodular and 5 infiltrative, 
desmoplastic) and further confirmed in a total of 153 cases of primary and metastatic 
melanomas. To investigate the function of nestin in modulating melanoma tumorigenic 
versus infiltrative growth, mRNA levels of metastasis-related genes including matrix 
metalloproteinases were compared in two melanoma cell lines with stable nestin gene 
knockdown. Subsequent analyses of nestin expression and melanoma growth pattern were 
performed in both in vitro cell migration and invasion and spherogenic growth and in vivo 
tumorigenic growth and invasion using mouse xenograft models.
Human melanoma specimens
The use of human melanoma specimens was approved by the Institutional Review Board of 
the Brigham and Women’s Hospital. Five purely nodular and 5 infiltrative/desmoplastic 
melanomas were screened from patients who underwent surgery. Additional 153 cases of 
primary and metastatic melanomas demonstrating clear nodular or infiltrative growth 
patterns were evaluated for nestin expression in melanoma tissue microarrays (TMA) 
purchased from Folio Bio (Powell, OH), US Biomax (Rockville, MD), and Imgenex (San 
Diego, CA). All cases were confirmed by a Board-certified dermatopathologist (GFM). In 
the TMA, nodular growth patterns involved coalescent, cohesive, and expansive regions 
formed primarily by rounded, epithelioid melanoma cells, whereas infiltrative growth 
patterns consisted of dyshesive nests, fascicles, and single cells that were often elongated to 
fusiform and that intermingled with and infiltrated through stroma. Although some of those 
with nodular growth patterns may have been melanomas of the so-called nodular vertical 
growth phase subtype, and some of those with infiltrative growth patterns may have 
represented more desmoplastic/sarcomatoid vertical growth phase variants, the TMA was 
not annotated such that these distinctions used in diagnostic classification could be made.
Routine histology
All human and mouse melanoma specimens were formalin-fixed, paraffin-embedded, 
sectioned, and stained with hematoxylin and eosin (H&E) for histopathological evaluation.
Immunohistochemistry and immunofluorescence staining
Immunohistochemistry and immunofluorescence staining was performed according to a 
standard protocol 13, 15. Sections were treated with heat-induced epitope retrieval using 
target retrieval solution (Dako, Carpenteria, CA, USA) and heated in a Pascal pressurized 
heating chamber (Dako, 125°C for 30 sec, 90°C for 10 sec). After incubation with primary 
antibodies at 4°C overnight, sections were incubated with HRP-conjugated secondary 
antibodies for 30 minutes at room temperature, and signals were visualized with NovaRED 
HRP substrate (Vector Laboratories, Burlingame, CA) with a hematoxylin counter stain. 
Alternatively, cells plated on chamber slides (ibidi µ-slide) were fixed in 4% 
paraformaldehyde, penetrated with 1% Tween-20, incubated with primary antibodies at 4°C 
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overnight, followed by incubation with fluorophore-conjugated secondary antibodies for 30 
minutes at room temperature. Isotype-matched immunoglobulin was used in place of 
primary antibodies as controls. Antibodies against human nestin 16 (1:200, Millipore, 
MAB5326), MMP3 17 (1:50, Abcam, ab32607), SOX2 15 (1:200, Neuromics, Edina, MN, 
GT15098), phospho-FAK (pT397) 18 (1:50, Cell Signaling, D20B1), and mouse F4/80 19 
(1:200, AbD Serotec, MCA497GA) and CD31 20 (1:100, Abcam, ab28364) were employed. 
MMP3 expression in melanoma cells was quantified by microdensitometry using ImageJ. 
Nestin staining was qualitatively evaluated as diffuse cytoplasmic (a pattern that produced 
apparently stronger reactivity and that characterized more rounded melanoma cells that grew 
in cohesive and expansive nodules), and sub-plasma membranous (a pattern that resulted in 
apparently weaker reactivity and that tended to be restricted to more elongated to fusiform 
melanoma cells showing stromal infiltration). Subcellular patterns of pFAK redistribution 
were quantified as previously described18.
Cell culture
Human melanoma cell A2058 and A375 and transformed human embryonic kidney cell 
HEK293T were originally obtained from American Type Culture Collection (Manassas, 
VA). Cells were recently confirmed to have no mycoplasma contamination by PCR 21. All 
cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Lonza, Hopkinton, 
MA). Culture media were supplemented with 10% heat inactivated fetal bovine serum (FBS, 
HyClone), 200 mM L-glutamine, 100 IU/ml penicillin and 100 µg/ml streptomycin (P/S/G, 
Life Technologies, Carisbad, CA), and maintained at 37°C, 5% CO2. If not otherwise stated, 
subconfluent cell culture was treated with 0.25% trypsin/EDTA solution (Hyclone) at 37°C 
for 1–2 minutes. Single cells were washed and resuspended in complete medium and stained 
with trypan blue. Viable cells were counted under a hemocytometer, and seeded on tissue 
culture plates. Cells were treated with TGF-β1 (Peprotech, Rocky Hill, NJ) at 5 ng/ml for 3 
days or focal adhesion kinase (FAK) inhibitor PF-573228 (Sigma-Aldrich, St. Louis, MO) at 
1 µM for 24 hours and harvested for analysis.
Knockdown of nestin
Nestin expression was knocked down (KD) by a lentivirus-based shRNA approach. shRNA 
vectors specifically targeting nestin (TRCN000014728 and TRCN000014729) were 
purchased (Sigma-Aldrich, St. Louis, MO). A non-targeting, scramble vector (SHC002, 
Sigma-Aldrich) or eGFP-targeting vector (SHC005, Sigma-Aldrich) was used as vector 
control (Vec). shRNA lentiviruses were produced in HEK293T cells by co-transfecting 
shRNA vectors with packaging vectors pHR’8.2dR and pCMV-VSV-G (gifts from Robert 
A. Weinberg, Whitehead Institute) into subconfluent HEK293T cells with FuGENE 6 
(Promega, Madison, WI) as described before 15. Viral supernatant was collected at 48 hours 
post transfection and filtered through 0.45 µm filters to remove cell debris. 5×104 target cells 
were seeded in each well of 6-well culture plates. After overnight culture, cells were 
transfected with 2 ml of viral supernatant containing nestin-targeting shRNA or control 
vectors in the presence of polybrene (8 µg/ml) for 8 hours, and allowed to recover in 
complete media. Twenty-four hours post transfection, transduced cells were selected with 
puromycin (1 µg/ml). Efficacy of nestin KD was assessed by quantitative RT-PCR and 
Western blot. Among the shRNA vectors examined, TRCN000014728 targeting nestin 3’-
Lee et al. Page 4
Lab Invest. Author manuscript; available in PMC 2015 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
UTR gave the highest nestin knockdown efficiency and was routinely used in this study. To 
exclude the possibility of off-target effects of shRNA, nestin-specific shRNA vectors 
TRCN000014729 was used to validate the effect on downstream gene expression.
Gene Expression Analysis
Total RNA was extracted (RNeasy mini Kit, Qiagen, Valencia, CA) from adherent vector 
control, nestin KD cells, and melanoma spheres in spherogenic culture. cDNA was 
synthesized from total RNA using SuperScript III First-strand Synthesis System (Invitrogen, 
Carisbad, CA) and served as the template for gene expression analysis. Relative expression 
of 84 genes involved in cell migration and metastasis were compared between A2058 Vec 
control and nestin KD cells using a human tumor metastasis PCR Array (PAHS-028A, 
SABiosciences, Frederick, MD). Results from the PCR array were further validated by real-
time quantitative RT-PCR in triplicate using Applied Biosystems 7300 system (Foster City, 
CA) and the ΔΔCt analysis method as mentioned previously 15. Taqman quantitative PCR 
primers of human nestin (Hs00707120_s1), SOX2 (Hs00602736_s1), OCT4 
(Hs00742896_s1), CD271 (Hs00609976_m1), MMP2 (Hs01548727_m1), MMP3 
(Hs00968305_m1), MMP9 (Hs00234579_m1), TIMP1 (Hs00171558_m1), TIMP2 
(Hs00234278_m1), and actin (4310881E) were purchased from Applied Biosystems. 
Primers of MMP1, MMP7, MMP10, MMP11, MMP13, TIMP3, TIMP4, and GAPDH were 
designed in house for SYBR Green quantitative PCR reaction (Table S1). Changes of 
mRNA levels > 2-fold were considered significant.
Western Blot
Subconfluent cell cultures and culture medium were collected for Western blotting analysis. 
Adherent cells were treated with non-enzymatic cell dissociation buffer Versene (Life 
Technologies), collected, washed twice with PBS, and lysed in cell lysis buffer (Cell 
Signaling, Danvers, MA) containing proteinase inhibitor cocktail and PMSF. Protein content 
was determined by bicinchoninic acid assay kit (Thermo Scientific, Rockford, IL). An equal 
amount of total proteins in cell lysate (100 µg) and 50 µl cell culture medium (equivalent to 
2×105 viable cells/ml) was separated on SDS-PAGE (4–12% Bis-Tris, Invitrogen) at 100 
volts at 4°C for 3.5 hours, transblotted onto nitrocellulose membrane at 340 mA at 4°C for 
1.5 hours, and blocked with 5% non-fat milk in TBS/0.1% Tween 20 (TBST) at room 
temperature for 1 hour. The membrane was incubated with primary antibodies at 4°C 
overnight with constant shaking. After washing three times for 5 minutes in TBST, the 
membrane was incubated with horseradish peroxidase (HRP)-conjugated secondary 
antibodies at room temperature for 30 minutes, washed again with TBST three times, and 
immunoreactive bands were detected by chemiluminescent reagents (Thermo Scientific) 
according to manufacturer’s protocol. Chemiluminescence was visualized using CL-
XPosure film (Thermo Scientific) or ChemiDoc+ XRS (Bio-Rad). Densities of immunoblot 
bands were quantified by ImageJ and normalized to β-actin. Antibodies for the Western blot 
were commercially available for mouse anti-nestin 22 (1:1,000, Millipore, MAB5326, clone 
10C2, Billerica, MA), rabbit anti-MMP1 (1:1,000, Abgent, AP11874c, clone RB18908, San 
Diego, CA), rabbit anti-MMP3 23 (1:1,000, Abcam, ab53015, Cambridge, MA), mouse anti-
MMP9 24 (1:1,000, Abcam, ab58803, clone 56-2A4), rabbit anti-MMP10 25 (1:1,000, 
Abcam, ab28206), rabbit anti-FAK 18 (1:1,000, Cell Signaling, #3285), rabbit anti-phospho-
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FAK (pT397) 18, (1:1,000, Cell Signaling, D20B1), and mouse anti-β-actin 26 (1:10,000, 
Abcam, ab6276, clone AC-15).
Cell Proliferation Analysis
To measure cancer cell proliferation in adherent monolayer culture, 100,000 viable cells/
well were seeded on 6-well tissue culture plates in six replicates. Viable cells were 
quantified by trypan blue exclusion using a hemocytometer at 72 hours.
Melanoma Cell Culture on Matrigel
Matrigel (50 ul, Dickinson Bioscience, Bedford, MA) was spotted onto 6 cm cell culture 
plates and allowed to set at 37°C for 2 hours. A2058 cells (2×103 viable cells per 10 ul 
complete medium) were loaded over Matrigel, incubated at 37°C, 5% CO2 for 2 hours, 
overlaid with complete medium and cultured for 10 days. Cells on Matrigel were fed with 
0.5 ml of fresh medium twice a week 27. Melanoma spheres on Matrigel were fixed with 
formalin and embedded in paraffin. Sections perpendicularly across Matrigel were stained 
with H&E and photographed for histological analysis. Spheres with less than 20%, 20–
100%, and 100% of sphere depth invading into Matrigel surface were defined as surface, 
partial invasion, and complete invasion into Matrigel, respectively. Numbers of melanoma 
spheres that invaded into Matrigel were counted and compared by a Chi-square test.
Anchorage-independent cell culture
Anchorage-independent spherogenic cell culture 28 was performed in suspension or in soft 
agar culture with the culture medium devoid of epidermal growth factor (EGF) and basic 
fibroblast growth factor (bFGF) which may potentially alter nestin expression 29, 30. For 
melanosphere culture in suspension, melanoma cells were cultured at low cell plating 
density (2,000 viable cells per 6-well or 1,000 viable cells per 24-well) in DMEM 
supplemented with 10% FBS, P/S/G, and 0.5% methyl cellulose (Sigma-Aldrich) in the 
ultra-low attachment plates (Corning, Acton, MA), and maintained at 37°C, 5% CO2 for 14–
21 days. Melanoma spheres were fed with 0.5 ml of fresh medium twice a week. Serial 
passage of melanoma spheres was performed to confirm in vitro self-renewal capability. 
Melanoma spheres were dissociated with 0.25% trypsin/EDTA solution at 37°C for 3–5 
minutes, and single cells derived from melanoma spheres were plated in the ultra-low 
attachment plates and allowed to form secondary spheres for 14 days. For soft agar culture, a 
6-well plate was covered with DMEM medium containing 10% FBS, P/S/G, and 1% agar 
noble (BD Biosciences, San Jose, CA), overlaid with 25,000 viable cells in culture medium 
containing 0.4% agar at 37°C, 5% CO2 for 28–35 days. Soft agar colonies were fed with 1 
ml of fresh medium containing 0.35% agar weekly. Spheres and colonies were stained with 
200 ul of 0.4% p-iodonitrotetrazolium violet (Sigma-Aldrich) overnight and photographed 
by a Canon T1i camera and Sigma 50mm/f2.8 macro lens. Numbers of spheres and colonies 
from triplicate experiments were counted by ImageJ (National Institutes of Health, ver. 
1.44k).
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Cell migration analysis
BioCoat 24-well control inserts (Becton Dickinson Bioscience, Bedford, MA) were used for 
tumor migration analysis. Vector control and nestin KD cells were collected from 
subconfluent cultures by Versene (Life Technologies), washed with PBS, and resuspended 
in loading media of DMEM containing 0.1% bovine serum albumin. Single cell suspension 
were stained with trypan blue and counted under a hemocytometer. 1×104 viable cells in 0.2 
ml of loading media were loaded onto control inserts, 0.75 ml of DMEM containing 10% 
FBS was added to the outer well immediately, and incubated at 37°C, 5% CO2 for 4, 6, and 
8 hours. After incubation, unwanted cells were removed by scrubbing, and cells on the other 
side of the control insert membrane were fixed by 10% formalin and stained with 
hematoxylin and 0.1% ammonium hydroxide. Cell counting was facilitated by 
photographing at three randomly selected fields at 10× magnification on each control insert 
membrane. Six replicates were set up for each cell line; migrating cells (on the lower surface 
of control insert membranes) and non-migrating cells (on the upper surface of control insert 
membranes) were counted in triplicate. To control loading error, percent cell migration 
through the control insert was calculated by dividing the mean number of migrating cells by 
total cell number loaded (sum of migrating cells and non-migrating cells). A two-sample Z-
test was used to assess whether the probability of cell migration in nestin KD groups 
differed from vector control groups. A p-value less than 0.05 is considered significant.
Matrigel invasion analysis
BioCoat control inserts and growth factor reduced Matrigel invasion chambers (Becton 
Dickinson Bioscience) were used for Matrigel invasion assays as described previously 15. 
Vector control and nestin KD cells were prepared as mentioned above in the migration 
analysis. 1×104 viable cells in 0.2 ml of loading media and 2.5×104 viable cells in 0.5 ml of 
loading media were loaded onto a control insert and a Matrigel insert, respectively, and 0.75 
ml of DMEM containing 10% FBS was added to the outer well immediately and incubated 
at 37°C, 5% CO2 for 20 hours. After incubation, non-migrating cells were removed from the 
upper surface of insert membranes by scrubbing, and migrating cells on the lower surface of 
insert membrane were stained and counted as mentioned above. Triplicates were set up in 
control and Matrigel inserts for each cell line. To characterize the function of MMP 
enzymatic activities in Matrigel invasion of A2058 and A375 nestin KD cells, MMP3-
selective inhibitor UK356618 (Tocris, Bristol, UK) at 20 nM (IC50=5.9 nM) 31 and the 
broad spectrum MMP inhibitor Marimastat (Tocris) at 20 nM (IC50=5, 6, 3, 13, and 9 nM 
for MMP-1, 2, 9, 7, and 14, respectively) 32 were added to the loading media within the 
insert and complete media in the outer well. These two MMP inhibitors were selected 
because of their potent inhibitory activities and no known cytotoxicity or adverse effect on 
cell proliferation 32. To control the difference in cell migration and loading error, percent 
Matrigel invasion was calculated by dividing the mean number of migrating cells on the 
lower surface of Matrigel invasion chambers by the mean number of migrating cells on the 
lower surface of the control inserts.
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Mouse xenograft and histological analysis
Specific pathogen-free, female NOD.CB17-Prkdcscid/J (NOD/SCID) or male NOD.Cg-
PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice were originally purchased from the Jackson Laboratory 
(Bar Harbor, ME) and were maintained in accordance with the institutional guidelines of 
Children's Hospital Boston and Harvard Medical School. Experiments were performed 
according to approved experimental protocols 33, 34. A2058 vector control and nestin KD 
cells derived from subconfluent monolayer culture were injected subcutaneously into the 
flanks of mice at 6–8 weeks of age. To ensure tumor formation for evaluation of tumor 
invasion into stroma and macrophage and vascular invasion into tumors, and diminish the 
potential influence of nestin knockdown in xenograft tumor formation due to changes in the 
frequency of malignant melanoma initiating cells (MMIC) 13, melanoma cells were injected 
into both flanks of NSG and right flanks of NOD-SCID mice at 1×106 (N=16 injections per 
cell line, 2 injections each mouse) and 3×106 (N=5 injections per cell line, one injection 
each mouse) viable cells in 100 µl PBS, respectively. Sample sizes of animal studies and cell 
numbers injected were based on pilot studies and previously published approaches 10, 35 by 
our laboratory, as the differences evaluated focused on qualitative parameters involving 
detection of invasion and protein expression based on immunohistochemistry. No animals 
were excluded from analysis. Tumor size was measured weekly with a caliper and tumor 
volume was calculated as 3.14/6×L×W×W. Mice were euthanized on 7, 14, and 20 days 
(NSG mice), or on 28 days (NOD/SCID) post tumor inoculation. Tumors were fixed in 
formalin and embedded for histological analysis. Investigators were not blinded to group 
allocation during the experiment or when assessing initial outcomes. However, to further 
validate outcome when qualitative parameters were primary read-out, blinded observers 
were required to assign accurately the outcome parameters in a prospective manner to each 
of the experimental conditions.
Statistical analysis
All experiments were technical triplicates or greater. Data were compared by two-tailed 
Student's t-test unless otherwise stated. One-way ANOVA test with Tukey’s multiple 
comparison was used when more than two samples were compared. Nestin distribution in 
nodular and infiltrative patient melanoma and nestin subcellular distribution were compared 
by Chi-square test. Statistical analysis was performed using GrapdPad Prism 5 (GrapdPad 
Software Inc., La Jolla, CA). Data are presented as mean ± standard error of the mean 
(s.e.m.). A p-value < 0.05 is considered significant.
Results
Nestin affects melanoma matrix metalloproteinase (MMP) expression
We initially produced nestin KD lines in A2058 and A375 cells, one derived from primary 
skin melanoma (A375), one from lymph node metastasis (A2058) 36. Nestin mRNA levels, 
averaged over a minimum of four replicate determinations, were significantly 
downregulated in nestin KD cells of A2058 (89.5% decrease, p<0.001) and A375 (91.4% 
decrease, p<0.001) lines, as compared to vector controls (Figure 1a). Decreased nestin 
protein levels were confirmed in nestin KD A2058 (92.7% decrease) and A375 (97.7% 
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decrease) cells as compared to vector control cells by Western blotting (Figure 1b). Nestin 
KD did not significantly influence overall proliferation in bulk cultures (Figure 1c).
Because nestin expression has been shown to correlate with invasion and metastasis of 
certain cancers 7, 37, 38, we next examined the relationship between nestin and 84 tumor 
epithelial-mesenchymal transition (EMT)/metastasis-related genes. Among these, nestin KD 
most profoundly affected the expression of MMP genes (Figure 1d and e). Specifically, 
mRNA levels of MMP1, 3, 9, and 10 were significantly upregulated in both A2058 and 
A375 lines (Figure 1d and e). Western blot analysis confirmed upregulation of MMP1 and 3 
proteins in lysates of nestin KD A2058 cells and MMP1 in nestin KD A375 cells; as well as 
MMP1, 3, and 10 in supernates of nestin KD A2058 cells and MMP1 and 10 in nestin KD 
A375 cells (Figure 1f). There was no detectable MMP9 in A2058 cells and MMP3 and 10 in 
A375 cells (Figure 1f). To establish further the apparent regulatory influence of nestin on 
MMP expression and exclude the possibility of off-target effects of nestin shRNA, 
additional nestin shRNA construct transfected into A2058 cells validated that mRNA levels 
for MMP1, 3, and 10, were significantly upregulated as a consequence of confirmed nestin 
KD (supplemental Figure 1). There was no compensatory change in mRNA levels of tissue 
inhibitor of metalloproteinase 1–4 (TIMP1-4) expression with nestin KD in A2058 cells or 
in TIMP1-3 in A375 cells (data not shown). These results suggested a reciprocal relationship 
in the melanoma lines tested between expression of nestin and certain MMPs known to 
enhance tumor invasion 39.
Nestin KD-associated MMP upregulation enhances melanoma invasion in vitro
The effects of nestin expression on cell migration and the ability of melanoma cells to 
traverse an ECM barrier facilitated by serum-mediated chemotaxis were next assessed. To 
control loading error, cells migrated through microporous transwell or Matrigel were 
normalized to total loaded cells or to non-Matrigel control insert, respectively. The 
migratory kinetics of both control melanoma cells and nestin KD melanoma cells through 
microporous transwell assays were similar, with increments for the first 6 hours, followed by 
gradual decrements thereafter, although a significantly lower percentage of nestin KD cells 
migrated by the 6 and 8 hour timepoints.(Figure 2a). However, nestin KD cells exhibited 
significantly greater ability to invade through ECM barriers containing collagen and 
basement membrane proteins (Matrigel-coated transwell membranes) when compared to 
vector controls after 18 hours (Figure 2b and c). Additional nestin shRNA construct 
transfected into A2058 cells further validated significantly enhanced Matrigel invasion in 
nestin KD cells and further ruled out the possibility of off-target effects of nestin shRNA on 
invasion (supplemental Figure 1d). The potential contribution of MMPs to nestin KD-
enhanced invasion next was addressed using the MMP3-specific inhibitor UK356618 31, 
which suppressed invasion of A2058 nestin KD cells by 33%. The broad-spectrum MMP 
inhibitor, Marimastat 32, had a slightly greater effect (43% inhibition), and combination of 
UK356618 and Marimastat resulted in further enhancement of inhibition (56%) (Figure 2d). 
In A375 nestin KD cells where MMP3 protein was not upregulated in comparison to A2058 
(Figure 1F), Matrigel invasion was suppressed by Marimastat by 45% but not by the MMP3 
inhibitor, UK356618 (Figure 2d). These data collectively support a role for MMP induction 
in nestin KD cells in facilitating in vitro ECM invasion.
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Nestin KD is associated with decreased sphere formation in vitro
Melanospheres are 3-dimensional micronodular aggregates of cohesive tumor cells that 
develop from melanoma cells exhibiting anchorage-independent growth 28. Melanospheres 
thus have been proposed to recapitulate, in part, tumorigenic growth due to self-renewing 
subpopulations in vivo 28, 40. To determine the potential relationship of nestin expression to 
three-dimensional spherical growth potential, we generated melanospheres avoiding serum-
free media that requires supplements known to influence nestin expression 29, 30. Cells 
forming melanospheres showed self-renewal capability confirmed by serial passage, and 
when compared to adherent cells, expressed mRNA for nestin, CD271, OCT4, and 
SOX2 7, 11, 35, 41 (data not shown). Nestin KD lines had significantly decreased anchorage-
independent growth and sphere-forming ability compared to their vector controls in 
suspension culture (Figure 2e) as well as diminished colony formation in soft agar culture. 
When melanospheres were grown on Matrigel membranes in the absence of a chemotactic 
stimulus, those that formed from nestin KD cells were irregularly-sized, internally 
dyshesive, and depleted of immunoreactive nestin (Figure 2f). In contrast, spheres derived 
from vector controls were uniform in size, cohesive, and replete with strong nestin 
immunoreactivity (Figure 2f). Remarkably, the poorly-formed nestin KD melanospheres 
penetrated into the Matrigel membrane, in contrast to vector control melanospheres that 
remained localized to the ECM surface (Figure 2f). These results suggest that nestin 
expression favors 3-dimensional spheroidal growth that may be partially switched to a less 
spherogenic, more invasive phenotype as a consequence of nestin KD.
Nestin KD is associated with stromal invasion in vivo
To test whether the in vitro relationship between nestin and MMP expression is relevant in 
vivo, melanoma xenografts next were evaluated. In contrast to in vitro kinetics where we 
noted no differences in cell proliferation between bulk cultures of nestin KD and vector 
control melanoma cells, melanoma xenograft growth may be inhibited by nestin KD when 
cell inoculation is limited 7. Therefore we employed relatively high inoculation cell numbers 
(1×106 or 3×106) of A2058 cells calibrated to produce similar growth characteristics 
between tumors derived from nestin KD and vector controls (Figure 3a) in order to control 
for potential effects of differential cell proliferation on MMP synthesis 42. Nestin depletion 
was confirmed by immunohistochemistry in tumors derived from nestin KD cells, while 
nestin was abundantly expressed in tumors derived from vector control cells (Figure 3b). 
Consistent with our in vitro data, immunoreactivity for MMP3 was significantly increased in 
nestin KD tumors compared to vector controls, as confirmed by computer image analysis 
(48.18±1.525 versus 30.35±1.928) (Figure 3b). Tumors derived from vector control cells 
were composed of nestin-high and MMP3-low melanoma cells that formed smooth 
bordered, uniformly circumscribed nodules that interfaced sharply with adjacent stroma 
(Figure 3c). In contrast, tumors derived from nestin KD cells were comprised of nestin-low, 
MMP3-high melanoma cells that generated tumors with borders that focally were 
interrupted by jagged and irregular zones of early stromal invasion. The regions were 
prominent as early as 7 days after xenografting (Figure 3c), and the invasive relationship 
between tumor and adjacent stromal cells was further confirmed by intimate admixture of 
melanoma cells with CD31-endothelial cells and F4/80-positive macrophages (Figure 3c).
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Nestin expression correlates with infiltrative patterns in clinical melanomas
To determine whether nestin expression patterns seen in xenografts was reflected in clinical 
lesions, we first screened a small number of primary patient melanomas with tumorigenic 
(cohesive and expansive) growth patterns and found nestin to be abundantly expressed by 
immunohistochemistry throughout the cytoplasm of large rounded cells that formed 
cohesive tumor nodules (N=5) (Figure 3d). In contrast, melanomas with predominantly 
infiltrative patterns (e.g. desmoplastic melanomas) showed less prominent nestin reactivity 
that was primarily restricted to the sub-plasma membranous regions of cells (N=5) (Figure 
3d). These patterns were next evaluated in a larger cohort (N=153) of patient melanomas 
represented in tissue microarray, where a prominent cytoplasmic pattern of nestin 
distribution was observed preferentially in nodules formed by cohesive rounded tumor cells 
(91 of 111; 82%), and a weaker or mixed pattern was documented in infiltrative regions of 
melanomas composed of stroma-associated cells (42 of 42; 100%) (p<0.0001). To 
summarize, the trend was for the rounded cells that formed cohesive and expansive pattern 
melanoma nodules expressed strong nestin that was diffusely present throughout the 
cytoplasm of the majority of tumor cells. The often more fusiform cells that showed 
infiltrative patterns of stromal invasion, tended to contain many cells that expressed nestin in 
a peripheral, sub-membranous pattern, and therefore appeared overall to express less nestin 
by immunohistochemistry. Although TMA melanomas with characteristics of desmoplastic 
variants tended to be at the extreme end of this spectrum of submenbranous low nestin 
expression, other less desmoplastic yet still infiltrative pattern melanomas showed an 
admixture of cells with low submembranous nestin and high cytoplasmic nestin (mixed 
pattern). These in vivo experimental and clinical data are consistent with our in vitro 
findings implicating nestin and related MMP expression in tumorigenic and invasive 
melanoma phenotypes.
Possible mechanisms of nestin regulation of melanoma invasive phenotype: pFAK and 
TGF-β
Cancer cell invasion involves a complex series of highly orchestrated interactions involving 
alterations in cell shape and cytoskeletal structure, locomotion, cell-stromal adhesive 
properties, and protease secretion. Focal adhesion kinase (FAK) plays a central role in 
cancer cell motility, adhesion, and invasion 43. In this regard, recent evidence indicates that 
nestin downregulation in prostate cancer cell lines triggers a switch from characteristic 
intracellular and submembranous clumped expression patterns of phosphorylated FAK 
(pFAK) to exclusive and punctate cell membrane localization that promotes integrin 
clustering and results in pFAK- and integrin-dependent matrix degradation and an invasive 
phenotype 14. In melanoma cells, we found nestin KD to be associated with lower pFAK 
and unaltered total FAK protein in A2058 cells, and increased pFAK and total FAK protein 
levels in A375 cells (Figure 4a). Despite these variations in protein expression, dual labeling 
revealed that nestin KD in both melanoma cell lines produced pFAK relocalization that was 
remarkably similar to the pro-invasive pattern described as a consequence of nestin KD in 
prostate cancer cell lines 14 (Figure 4b). Specifically, the percentages of cells showing an 
exclusively membranous pattern increased as a function of nestin KD from 42.9% to 76.2%, 
and from 18.9% to 59.0% in A2058 and A375 cells, respectively (p<0.001). Moreover, 
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treatment with FAK inhibitor, PF-573228, did not significantly alter mRNA levels of MMP3 
and MMP9 in A2058 and A375 cells (data not shown).
FAK-dependent cancer cell transition to invasive phenotypes is known to involve 
transforming growth factor beta (TGF-β) 44, an established driver of cancer virulence 45 and 
melanoma invasiveness through upregulation of MMPs 46. Of further interest, TGF-β may 
directly influence nestin expression in pancreatic cancer cells 47. Although we did not find 
TGF-β to significantly alter nestin mRNA expression in either A2058 or A375 cells (Figure 
4c), it significantly upregulated MMP9 and 10 in A2058 and A375 cells (Figure 4d). Of 
interest, the effects of TGF-β on upregulation of MMP10 in A2058 cells, and MMP9 and10 
in A375 cells were significantly more robust in the setting of nestin KD (Figure 4e). 
Specifically, among the TGF-β-treated cells, nestin KD A2058 cells had significantly 
upregulated MMP10, and nestin KD A375 cells had significantly upregulated MMP9 and 
10, as compared to control cells (Figure 4e). These data suggest that although TGF-β does 
not directly regulate nestin expression in the melanoma cell lines under study, TGF-β-
mediated upregulation of certain MMPs is enhanced by low nestin expression.
Discussion
Nestin is a type VI intermediate filament characteristically expressed in physiologic neural 
stem cells and muscle progenitor cells 48, 49. Nestin regulates cell death in neural progenitor 
cells and podocytes of kidney 50, 51 and neuromuscular junction development 52 by a CDK5-
dependent mechanism. Although nestin has been associated with poor prognosis in both 
breast cancer and melanoma 53, 54, it is not established that nestin is an authentic stem cell 
marker in cancer, and mechanisms that link degree of nestin expression with known 
behavior of clinical tumors remain largely unexplored. Melanoma has long been considered 
as a paradigm for the study of cancer behavior and progression 55. Primary melanomas may 
grow in either or both nodular and infiltrative patterns 2, 4, the former more consistent with 
tumorigenesis driven by self-renewal, and the latter indicative of the ability of at least some 
cells to invade host tissues beyond the primary site. In this study, we asked whether nestin 
might relate to these two basic patterns of tumor growth. We find that nestin expression 
appears to correlate with these two potentially interchangeable phenotypes and provide 
potential mechanistic insights indicating that nestin regulates MMP production, a known 
mediator of the invasive growth phase of melanoma and other cancers.
Practically, clinical melanomas traditionally have been divided into subtypes based on 
presence and morphology of the radial growth phase and characteristics of vertical growth 
phase. Based on the cytology and architecture of the former, radial growth subtypes such as 
superficial spreading, lentigo maligna, acral lentiginous/mucosal have been designated. 
When radial growth fails to flank the invasive component for a span three or more epidermal 
rete ridges, melanomas are considered to be of the nodular subtype. Moreover, when deeper 
invasion constituting vertical growth phase is composed of more infiltrative patterns of thin 
spindle cells, as opposed of expansive nodules of epithelioid cells, descriptors such as 
desmoplastic and sarcomatoid may be added to describe these features. In our study, the 
majority of human melanoma specimens were from a TMA without annotation as to subtype 
or outcome, such that the correlative morphology presented refers strictly to growth patterns 
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(nodular versus infiltrative), rather than specific melanoma subtypes, their associated 
prognostic attributes, or relationship to patient survival.
The notion that cells forming tumorigenic nodules versus invasive fronts are fundamentally 
different is perhaps intuitive, as rounded cells that diffusely express cytoplasmic nestin and 
grow cohesively to form expansive nodules with little MMP expression are not 
physicodynamically or biochemically well-adapted to also navigate through spatial 
interstices and ECM barriers imposed by human dermis. Nonetheless, there exist conflicting 
studies that suggest that nestin expression mediates both three-dimensional tumorigenesis 
while at the same time driving an invasive phenotype 7, 38. Cell-cell contact is known to 
influence kinetics of cancer cell invasion 56, and in this regard our approach differs from 
previous studies by employing melanoma cell loading doses for Matrigel invasion assays 
that were lower by four-fold 7. In addition, our nestin knockdown strategy employed a 
shRNA construct that did not significantly alter melanoma cell proliferation, an additional 
potential factor in interpretation of such assays. In this regard, it is important to separate 
overall proliferation in bulk cell culture, which in our study was not affected by nestin KD, 
from nestin KD-induced inhibition of sphere formation that has been presumed to be driven 
by a self-renewing stem cell subcompartment. Moreover, our findings of enhanced invasion 
as a function of nestin KD are supported by both demonstration of induction of MMPs 
known to facilitate this process 39, 57, and by the ability to partially block this effect using 
specific 31 and broad-spectrum 32 MMP inhibitors. The concept of reciprocal switching 
between tumorigenic and invasive melanoma phenotypes is fortified further by recent 
studies by Hoek et al 58 who have provided complementary in vitro and in vivo evidence 
based on experimental downregulation of microphthalmia-associated transcription factor 
(MITF) gene expression. Because cancer cells may co-opt pathways integral to 
embryogenesis 59, it also is of interest that our findings in melanoma bear some resemblance 
to the phenomenon where stationary proliferating nestin-expressing neural crest stem cells 
lose nestin 8 as they acquire MMP expression 60 in conjunction with migration and 
differentiation. Finally, we noted no increase in TIMP1-4 expression with nestin KD in 
A2058 cells or in TIMP1-3 in A375 cells, suggesting that the biological effects of increased 
MMP expression by nestin KD may be independent of many of their primary endogenous 
inhibitors.
It is of interest that nestin KD failed to increase cell motility, cell invasion was enhanced. 
While our data does not provide fundamental insight in this regard, it is noteworthy that 
migration on a surface involves coordinated ability to loosen from adhesive interactions with 
adjacent cells mediated by cell adhesion molecules, gain traction with substrate through 
expression of integrins, and contract and expand via regulation of the actin-myosin complex. 
Invasion, on the other hand, requires additional assets, such as production of invasopodia 
that mediate initial proteolysis of extracellular matrix, and more focused proteolysis attained 
primarily via production of matrix metalloproteinases. Clearly the dominance of proteolysis 
over movement could produce situations whereby less motile cells are in fact more invasive. 
The prospect that less motile yet invasive cells might be better equipped to form metastases 
is a fascinating one, as the ability to shift from an invasive to a tumorigenic phenotype could 
be favored by immigrant cells capable of 'planting' themselves in the metastatic niche upon 
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arrival, a behavior conceivably favored by low migratory potential upon reaching their 
destination.
Mechanistically, the interactions between nestin and MMP expression are likely to be 
complex and involve multiple pathways. One insight in the present study into the effects of 
nestin expression on the invasive phenotype was provided by cell labeling for pFAK. Hyder 
et al 14 have recently observed that nestin downregulation in prostate cancer cell lines results 
in repositioning of pFAK from clumped cytoplasmic and submembranous regions to discrete 
punctate domains that exclusively decorate the cell membrane, and our findings in both 
A2058 and A375 nestin KD melanoma lines are remarkably similar. In contrast, 
pharmacological inhibition of FAK did not significantly alter MMP expression in the 
melanoma lines examined. Although this raises the possibility that invasive pathways 
involving FAK/integrin-mediated cell/matrix adhesion, may also be involved in nestin KD 
cells616263, our data is too preliminary to draw definitive conclusions at this juncture. FAK 
also is known to be involved in TGF-β adhesion-dependent signaling and MMP up-
regulation 44, 64. Moreover, melanoma cells and their microenvironment may constitutively 
secrete bioactive TGF-β 65, 66. While the upstream regulatory mechanisms for nestin 
expression remain largely unknown 67, a number of studies suggest that nestin itself may be 
influenced by extracellular stimuli 29, 30, 47, 68 such as TGF-β. Our data suggest that 
although TGF-β does not influence nestin expression, expression of certain MMPs is 
enhanced by TGF-β in association with nestin KD. TGF-β is abundantly expressed in human 
epidermis and dermis 69, and the possibility exists that it may serve as a microenvironmental 
stimulus to drive MMP expression in melanoma cells with low nestin, thus facilitating 
invasion. Nonetheless, our data also indicate that nestin also has TGF-β-independent 
functions. Additional studies are now indicated to better understand the molecular linkages 
between microenvironment, nestin, MMPs, FAK, and stromal invasion.70
In summary, our data support a reciprocal relationship between expression of nestin and 
certain MMPs important in transition to an invasive phenotype, and begin to probe 
molecular mechanisms potentially involved in nestin/MMP interactions. While none of the 
assays used or mechanisms explored permit a definitive conclusion of a "nestin/MMP 
invasive switch", the findings for the first time provide a framework for understanding 
nestin function in melanoma biology. Moreover, the results obtained are internally 
consistent in supporting a role for nestin in the as yet unsolved mystery of how melanomas 
express a complementary duality involving tumorigenic and invasive growth in a manner 
that appears to synergize to drive virulence. Practically, nestin immunohistochemistry of 
patient biopsies has focused to date on correlating the intensity of its expression with 
aggressive behavior 7, 53, 54, as assessed by the formation of durable metastases or their 
clinical consequences. This now must be re-examined in the context of a more complex 
nestin profile where variation in nestin expression may define subpopulations differentially 
capable of the tumorigenic or invasive growth that likely must collaborate to spawn 
clinically significant metastases. Because the nestin-rich tumorigenic growth phase likely 
requires coordinated and bidirectional interaction with the nestin-poor infiltrative phase in 
order to drive tumor dissemination, studies are also indicated to screen for the effects of 
endogenous pathophysiologic mediators that are abundant in the melanoma stromal 
microenvironment 71 and that may be capable of influencing nestin expression. 
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Translationally, nestin transcription is known to be epigenetically regulated by histone 
acetylation that itself may be influenced by retinoic acid 72, an agent known to inhibit 
melanoma virulence-associated gene expression 73. Accordingly biological modifiers of 
nestin expression should now be further examined in the context of melanoma therapeutics.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Nestin affects melanoma MMP expression
(a) Nestin mRNA levels were significantly down-regulated in nestin KD cells (NesKD, 
black bars) of A2058 (90% decrease) and A375 (91% decrease,), as compared to vector 
control cells (Vec, white bars). (b) Decreased nestin protein levels were confirmed in nestin 
KD A2058 (92.7% decrease) and A375 (97.7% decrease) cells as compared to vector control 
cells by Western blot. (c) Nestin KD did not significantly alter cell proliferation in A2058 
and A375 cells. (d) Compared to A2058 Vector control cells (white bars), A2058 Nestin KD 
cells (black bars) had significantly higher mRNA levels of MMP1, MMP3, MMP9, and 
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MMP10. e) Compared to A375 Vector control cells (white bars), A375 Nestin KD cells 
(black bars) had significantly higher mRNA levels of MMP1, MMP3, MMP9, and MMP10. 
(f) Western blot confirmed that A2058 Nestin KD cells had marked higher protein levels of 
MMP1 (3.2-fold) and MMP3 (31.2-fold) in cell lysate and secreted MMP1 (3.0-fold), 
MMP3 (19.9-fold), and MMP10 (60.7-fold) in supernatant. MMP9 protein in supernatant of 
A2058 cells was below detection limit of immunoblotting. A375 Nestin KD cells had 
marked higher protein levels of MMP1 (7.3-fold) in cell lysate and secreted MMP1 (4.4-
fold) and MMP9 (11.1-fold) in supernatant. MMP3 protein in cell lysate and supernatant of 
A375 cells were below detection limit of immunoblotting. MMP9 and MMP10 proteins in 
cell lysate of A2058 and A375 cells were below detection limits of immunoblotting and thus 
data was not shown.
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Figure 2. Nestin KD enhances melanoma invasion in vitro and decreases sphere formation
(a) Note significant diminished cell migration of nestin KD cells (NesKD, solid lines) as 
compared to the vector control cells (Vec, dash lines) of A2058 (left; p<0.00001 at 6 and 8 
hours, respectively) and A375 (right; p<0.00001 at 6 and 8 hours, respectively). (b) 
Representative fields of migrating A2058 (left) and A375 (right) cells in Matrigel inserts 
(top panel) and control inserts (bottom panel). Scale bars: 50 µm. (c) Nestin KD cells (black 
bars) had significantly higher Matrigel invasion than vector control cells (white bars) of 
A2058 (left, 2.54-fold, p<0.001) and A375 (right, 4.02-fold, p<0.001). (d) Matrigel invasion 
of A2058 and A375 nestin KD cells was characterized in the presence of MMP3-specific 
inhibitor UK356618 or the broad spectrum MMP inhibitor Marimastat. Compared to 
untreated A2058 nestin KD cells (black bar), UK356618 (20 nM, 33% decrease, p<0.05) 
and Marimastat (20 nM, 43% decrease, p<0.01) significantly suppressed Matrigel invasion 
of A2058 nestin KD cells. Combinatorial treatment of UK356618 (20 nM) and Marimastat 
(20 nM) additively suppressed Matrigel invasion of A2058 Nestin KD cells (56% decrease, 
p<0.001). Additionally, Matrigel invasion of A2058 nestin KD cells with combinatorial 
treatment of UK356618 and Marimastat was lower than monotherapy with UK356618 
(65%, p=0.097). Likewise, in A375 nestin KD cells, Matrigel invasion of A375 nestin KD 
cells was not altered by UK356618 (20 nM), but was significantly suppressed by Marimastat 
(20 nM) (45% decrease, p<0.01) or by combinatorial treatment of Marimastat (20 nM) and 
UK356618 (20 nM) (55% decrease, p<0.001), as compared to untreated cells (black bar). 
Additionally, Marimastat monotherapy and combinatorial treatment of Marimastat and 
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UK356618 had comparable suppressive effects on A375 nestin KD Matrigel invasion. 
Results were compared by one-way ANOVA test with Tukey’s multiple comparison test. 
Representative cell migration and invasion results are shown from at least three independent 
assays. (e) Representative images of A2058 and A375 melanospheres in spherogenic 
suspension culture in DMEM supplemented with 10% FBS and 0.5% methyl cellulose for 
21 days. Melanospheres were visualized with p-iodonitrotetrazolium violet staining. Note 
marked decreased of sphere formation in both A2058 (top) and A375 (bottom) nestin KD 
cells as compared to vector control control cells (both p<0.01, respectively). Representative 
results are shown from two independent experiments. (f) H&E and IHC images of spheres 
growing over Matrigel. A2058 vector control spheres grew mainly on the surface of 
Matrigel (top), while nestin KD spheres invaded into the lattice of Matrigel (bottom). Scale 
bars: 50 µm Location of spheres on Matrigel. Majority (83.3%) of A2058 vector control 
spheres grew on the surface of Matrigel (white bar), while 16.7% partially invaded into 
Matrigel (gray bar). In contrast, 28.3% nestin KD spheres grew on the surface of Matrigel 
(white bar), 25% partially invaded into Matrigel (gray bar), and 46.7% completely invaded 
and embedded into Matrigel (black bar). Difference in Matrigel invasion between 
melanospheres derived from A2058 vector control (N=60) and Nestin KD (N=60) cells was 
significant (p<0.0001, Chi-square test). Data is represented from two independent Matrigel 
sphere experiments. Nestin was abundantly expressed in the cytoplasm of vector control 
A2058-derived melanospheres grown in association with Matrigel (top), whereas decreased 
nestin protein levels in nestin KD A2058-derived spheres correlated with a localized 
submembranous pattern (bottom, arrows). Left panels: low magnification; right panels: high 
magnification. Scale bars: 10 µm. Note: * p<0.05, ** p<0.01, *** p<0.001.
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Figure 3. Nestin KD is associated with stromal invasion in vivo
(a) Tumors derived from A2058 nestin KD (NesKD, solid line) and vector control (Vec, 
dash line) cells had comparable growth rate in NOD-SCID mice at 3×106 cells/injection/
mouse (N=5). (b) Representative immunohistochemistry staining of nestin and MMP3 in 
A2058 xenograft tumors at 28 days post xenografting. Nestin KD tumors (bottom) had 
significantly enhanced MMP3 staining in the tumors confirmed with efficient nestin KD 
when compared to vector control tumors (top) where nestin was abundantly expressed 
(Nestin KD, black bar; vector control, white bar; both N=5, p<0.001). Scale bars: 50 µm. (c) 
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Representative H&E and immunohistochemistry staining of vector control (top) and nestin 
KD (bottom) tumors at 7 days post xenografting. In contrast to well-circumscribed 
subcutaneous nodules of vector control tumors (N=4), nestin KD tumors (N=4) had 
significant stromal invasions in multiple areas. Immunoreactivity of SOX2 stained both 
A2058 vector control and nestin KD tumor cells. Efficient nestin knockdown was confirmed 
in the nestin KD tumors. In contrast to dense cytoplasmic nestin staining in vector control 
tumors, submembranous pattern of nestin distribution was observed in localized, spindle 
cells scattered in nestin KD tumor (inset). Nestin KD tumors had enhanced MMP3 staining. 
CD31+ vessels and F4/80+ dendritic cells appeared at peritumoral stroma of vector control 
tumors, whereas these cells diffusely infiltrated nestin KD tumors. Scale bars: 50 µm. (d) 
Examples of patterns of nestin expression that may be detected in tumorigenic (nodular, top) 
and infiltrative (desmoplastic, bottom) regions of certain human primary melanomas. 
Nodular regions by hematoxylin and eosin (H&E) staining are well-circumscribed (broken 
line: border between tumor [right] and adjacent stroma [left]) and composed of coalescent, 
rounded cells that express abundant cytoplasmic nestin by immunohistochemical staining. 
Infiltrative regions, in comparison, show diffuse permeation of stroma by elongated spindle-
shaped cells that express quantitatively less nestin immunoreactivity that is localized to sub-
plasma membrane regions. Scale bars: 50 µm.
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Figure 4. Possible mechanisms of nestin regulation of melanoma invasive phenotype: pFAK and 
TGF-β
(a) pFAK was significantly lower (78% decrease) as a result of nestin KD in A2058 cells, 
while FAK protein levels were not changed (left panel); in contrast, pFAK and FAK were 
significantly higher (3.2-fold and 2.5-fold, respectively) as a result of nestin KD in A375 
cells (right panel). (b) Intracellular expression pattern of phosphorylated FAK (pFAK, red) 
in vector control nestin (green)-expressing cells of both A2058 and A375 lines consisted of 
coarsely-clumped intracellular and peripheral zones of immunoreactivity (upper panels, 
regions enclosed in broken square are shown at higher magnification directly beneath each 
panel; broken yellow lines approximate plasma membrane). In contrast, in nestin KD cells, 
pFAK was expressed only as discrete punctate cell membrane-associated domains (bottom 
panels). (c) Nestin mRNA levels were not significantly altered by TGF-β (black bars) in 
A2058 and A375 cells as compared to untreated cells (white bars). Average fold changes 
from at least two different batches of cells are shown. (d) Compared to untreated A2058 and 
A375 cells (white bars), TGF-β (black bars) upregulated MMP9 and 10 mRNA levels, but 
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did not alter mRNA levels of MMP1 and MMP3. Average fold changes from at least two 
different batches of cells are shown. (e) Compared to TGF-β−treated vector control cells, 
upregulation of MMP10 in A2058 nestin KD cells and MMP9 and 10 in A375 nestin KD 
cells was significantly further amplified in the setting of nestin depletion.
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